| 1BKC | A:; C:; E:; I: | CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) |
| 1ZXC | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) WITH INHIBITOR |
| 2A8H | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THIOMORPHOLINE SULFONAMIDE HYDROXAMATE INHIBITOR |
| 2DDF | A:; B: | CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH TAPI-2 |
| 2FV5 | A:; B: | CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH IK682 |
| 2FV9 | A:; B: | CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH JMV 390-1 |
| 3B92 | A: | NOVEL THIO-BASED TACE INHIBITORS PART 2: RATIONAL DESIGN, SYNTHESIS AND SAR OF THIOL-CONTANING ARYL SUFONES |
| 3CKI | A: | CRYSTAL STRUCTURE OF THE TACE-N-TIMP-3 COMPLEX |
| 3E8R | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR |
| 3EDZ | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR |
| 3EWJ | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH CARBOXYLATE INHIBITOR |
| 3G42 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF TACE WITH TRYPTOPHAN SULFONAMIDE DERIVATIVE INHIBITOR |
| 3KMC | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH TARTRATE-BASED INHIBITOR |
| 3KME | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH PHENYL-PYRROLIDINYL-TARTRATE INHIBITOR |
| 3L0T | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDANTOIN INHIBITOR |
| 3L0V | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THE FIRST HYDANTOIN INHIBITOR OCCUPYING THE S1' POCKET |
| 3LE9 | A:; B: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH INDAZOLINONE-PHENYL-HYDANTOIN INHIBITOR |
| 3LEA | A:; B: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH ISOINDOLINONE-BIPHENYL-HYDANTOIN INHIBITOR |
| 3LGP | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH BENZIMIDAZOLYL-THIENYL-TARTRATE BASED INHIBITOR |
| 3O64 | A:; B: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH 2-(2-AMINOTHIAZOL-4-YL)PYRROLIDINE-BASED TARTRATE DIAMIDES |
)
)